Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trialKohei Shitara, Min‐Hee Ryu, Lorenzo Fornaro et al.|The Lancet|2018Cited by 1.3k
A National Cancer Institute of Canada Clinical Trials Group Study – IND.135: Phase I/II study of irinotecan (camptosar), oxaliplatin and raltitrexed (tomudex) (COT) in patients with advanced colorectal cancerJean A. Maroun, G. Chiritescu, Derek J. Jonker et al.|European Journal of Cancer|2005Cited by 9
Health related quality of life in older or frail patients with advanced colorectal cancer treated with dose reduced capecitabineDaniel Breadner, Stephen Welch, Mark Vincent et al.|Journal of Geriatric Oncology|2018Cited by 4